Is true that corporate funded research is often far from truth?

Over the last two decades, government and non-profit funding has witnessed a significant decline while Industry or corporate funded research has seen a global growth. Two-thirds of medical research is now dominated by corporates since they fund it and that does not make things any good for the medical community. However, this practice is growing increasingly common among all prominent industries such as food and beverage, pharmaceutical, etc.

Because of this interference of other industries in the medical community, the research conducted is often not accurate or based on facts. It has been alleged that industries fund for research to pave the results in their favor although the funders has always been denying. This manipulation tamper’s with the trust of the funder’s consumer since they never really get to know the real deal and have to trust what the tampered results have to discuss.

Reference Link: https://theconversation.com/when-big-companies-fund-academic-research-the-truth-often-comes-last-119164

Tough breast cancer can be treated using an anti-evolution drug

New generation remedies for cancer treatments are challenging resilient cancer conditions in patients. Previously known as BOS172722, was tested in animals to study the effectiveness of paclitaxel which is kind of Chemotherapy used in treating triple-negative breast cancer, one of deadliest breast cancer known to mankind.

A human trial of this procedure is scheduled to be performed. If it is a success, it can be expanded to treat lung and ovarian cancer.

Reference Link: https://www.newscientist.com/article/2218935-anti-evolution-drug-may-help-treat-resistant-breast-cancers/

Alzheimer’s Association And Wiley Collaborate For Publishing

John Wiley and Sons Inc. and the Alzheimer’s Association partnered for their three publications namely Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association (A&D), Diagnosis, Assessment & Disease Monitoring (DADM), and Translational Research & Clinical Interventions (TRCI).

The journals will changeover to the Wiley Online Library platform after the publication of the November/December 2019 issue. Maria C. Carrillo, a Ph.D. holder and Chief Science officer of Alzheimer’s Association says “The Association is committed to accelerating the international effort to eliminate these devastating diseases, and these journals are an important forum for sharing the latest research about Alzheimer’s and related dementias with the global scientific community.”

Reference Link: https://newsroom.wiley.com/press-release/all-corporate-news/alzheimers-association-and-wiley-announce-publishing-partnership

Tips To Write An Article Review

According to ResearchGuide “An article review is a piece of writing where you summarize and assess another person’s article.”

A review paper is a professional paper writing which gives an in-depth analysis and a well-structured presentation of arguments. It is an acute and constructive evaluation of literature in a particular field by summarizing it. Writing a scientific review will give you access to database searches to frame the research. Its goal is to summarize everything and present a clear understanding of the topic of your choice.

There are different types of article review:

  • Journal: It is a type of article review that evaluates the strengths and weaknesses of a publication.
  • Research: In this type of review, the research method is evaluated to analyze and critique the given information.
  • Science: A scientific article review includes anything in the world of science.

Following are 6 key points to keep in mind when writing a review article:

  1. It is not a list of conclusions for a paper

Do you have something new to say or add the paper? This is an important question one should ask them before starting to write a review. The reader of your review should be able to learn and take away something of value from it.  Make it a point to include comparison, critique and assessment of the studies you are reviewing.

  1. Submit a proposal before writing a manuscript

It is advised to reach out to editors of the journal of your choice before writing a review since they will be able to guide you to understand whether or not writing this review will be of anyone’s benefit. This will increase your chances of getting your paper published.

For the proposal, give clear reasons why the particular topic/subject is important. You may need to give stronger reasons why you need to write this review.

  1. Have a good structure/framework of your article

After figuring out the purpose of writing this paper, move your focus to have a clear outline that will make you aware of the path you want to follow with this article. This not only makes your article much clearer but it will also help work on the DO’S and the DONT’S of your article review.

  1. Avoid using heavy words

Jargons could be easier for a seasoned researcher to understand but for someone who is starting off it could be really difficult. You are writing it as a subject expert but the person reading it may not be as skilled and informed as you are. Hence, this is an important thing to keep in mind that you’ve to write the review to appeal to the wider range of readers. In case you most definitely have to use technical terms, do not forget to mention them in the glossary.

  1. Always follow the journal’s guidelines

You wouldn’t want your review article to be rejected because you ignored this crucial step would you? Chances are you already know what journal guidelines are. If you don’t, it is basically set of rules that vary from journal to journal that instruct you on how to edit, format and submit your paper in a certain way that the particular journal follows before it is published. This is done to save time for the publisher and the writer.

  1. Read and re-read your first draft

As mentioned in previous blogs before, give your piece of work a fresh set of eyes i.e., ones you believe you have completed it take a break, get on to other ventures and work you have and come back after a few days. This will make it easier for you to spot any mistakes that you might have skipped over the first. You make this process faster, you may hire an editor who will do the same for you on your behalf and fine-tune it even further.

HighWire Strengthens Relationship with BMJ

HighWire has declared about their new journal hosting agreement with BMJ. HighWire has been associated with BMJ since 2005. This agreement has a five year contractual obligation and has been renewed for the third time.

They now have a joint innovation lab with BMJ and BMJ’S senior product and tech experts will be an important part of the operation. Allison Lang, Publishing Director at BMJ says, “Innovation is at the heart of what we do. The launch of our new innovation lab with HighWire means we can leverage the very best minds when it comes to technology at the forefront of digital knowledge management. Together we want to achieve new developments that not only enable provision of healthcare knowledge globally, but set new standards of excellence for STM publishing.”

Reference Link: https://www.businesswire.com/news/home/20190923005542/en/HighWire-Strengthens-Relationship-BMJ-Delivering-Improved-Hosting

Cambridge University press launches a new journal to tackle major problems in scholarly solution

Experimental Results, a new Cambridge University journal has been launched to take on problems faced by research scholars. This will allow unpublished research to use a platform and it will also make peer review faster.

Fiona Hutton, head of STM Open Access Publishing says “Scholarly communication isn’t really reflective of the research process, because the focus is on publishing a concise narrative. The reality is that research results are often confusing, inconclusive, or don’t fit a narrative.”

Reference Link: https://www.cambridgenetwork.co.uk/news/new-journal-aims-tackle-biggest-problems-scholarly-communication

BMJ launches new open access journal

BMJ launches BMJ Surgery Interventions & Health Technologies open access journal to its expanding portfolio that houses more than 70 specialist journals. BMJ SIT is dedicated to the latest advancements in the field of surgical therapeutic devices and interventional procedures.  Its aim is to encourage high quality scientific knowledge and innovations in the field. The title will offer an impactful international platform for both early and later-stage clinical studies. It will be focusing on fast submissions and review processes with continuous publication online.

Professor Art Sedrakyan, of Weill Cornell Medical College New York said “Our ambition is to publish high-quality evidence at all stages of the life cycle of innovative as well as widely adopted surgical therapeutic devices and interventional procedures. It is my hope that this innovation in healthcare interventions will improve not only patient outcomes but the overall quality of care and treatment patients receive.”

Reference Link: https://www.bmj.com/company/newsroom/bmj-launches-new-open-access-journal-on-complex-healthcare-interventions/

Springer Publishing Company’s manuscript submission is now a part of ScholarOne

Springer Publishing Company has moved its manuscript submission and peer review system to ScholarOne. This agreement covers all of Springer Publishing Company’s journals as well as Publons Reviewer Recognition and Reviewer Connect services. Springer Publishing will have access to the new AI-controlled article scanning features that ScholarOne has.

Adam Etkin, editor for journals at Springer Publishing Company said “When considering a new provider for our peer review system, it was important to choose an innovative and publisher-independent organization to handle the most important services for our research community.”

Reference Link: https://www.researchinformation.info/news/springer-moves-scholarone

How to give the best presentation of your scientific poster

Presentation of any kind could be daunting especially when it is done to an audience. But when it comes to a researcher presenting a scientific poster to the audience of a science conference, understanding your work in-depth will help present it smoothly. Conferences can be a great way to socialize among researchers from the same field and get feedback on your work.

For those of you who are new to this area or you are an aspiring researcher in your favorite field, scientific poster is a tool of communication that combines verbal communication with visual aid.

Here is how you can establish great contacts and make major career developments with simple steps:

Dress to impress

It should give off a professional yet warm vibe while being subtle about it. You can do this!

Make your poster attractive at its best

Don’t add too much or too little components. Take your time to make this one.

Be cordial and welcoming

“A smile goes a long way! And a little bit of “hi and hello” thrown into the mix will do no harm. You may have noticed that stalls that have idle people managing it receive little to no visitation. It gives off a vibe that they are closed even when they are not. You have to be on your feet and ready to spot people and pull them to your stall.

Practice the art of “The Elevator Pitch”

Once you have piqued the interest of your potential audience, be on standby mode to explain your work with a short synopsis. Make sure to avoid using jargons while explaining and do not be too fast. Stay calm! Who knows there might be a potential funder among them?

Never be shy to share the story of your journey

Once you have their attention and their interest in your work, relax a little and let down your guard. Let them know about the motivation behind your work and journey so far. It is advised to proceed in this direction only when asked about it.

Common drug used in treating Alzheimer’s disease Increases risk of hospitalization

Donepezil, a drug that is commonly used in treating Alzheimer’s disease and many forms of dementia has been associated with increased risk of hospitalization for rhabdomyolysis, a painful condition of muscle breakdown.

Rhabdomyolysis may also result in kidney-related diseases as well. Doctors suggest that the risk is low yet a statistically significant one.

Reference Link: https://scitechdaily.com/commonly-used-drug-for-alzheimers-disease-doubles-risk-of-hospitalization/